LBA Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$7K Hold
40
﹤0.01% 340
2016
Q4
$6K Hold
40
﹤0.01% 354
2016
Q3
$5K Sell
40
-50
-56% -$6.46K ﹤0.01% 369
2016
Q2
$12K Hold
90
0.01% 293
2016
Q1
$13K Sell
90
-130
-59% -$17.4K 0.01% 280
2015
Q4
$31K Hold
220
0.02% 231
2015
Q3
$31K Hold
220
0.02% 202
2015
Q2
$36K Buy
+220
New +$35.1K 0.02% 182
2014
Q4
Sell
-100
Closed -$12K 324
2014
Q3
$12K Buy
+100
New +$11.5K 0.01% 268

Other funds holding ELV

LBA Wealth Management's ELV Position: Q1 2017 in Review

LBA Wealth Management held its Elevance Health (ELV) position steady in Q1 2017 at 40 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

LBA Wealth Management first reported a position in ELV in Q3 2014 and has held it in 9 quarters since. The position peaked at $36K in Q2 2015. 795 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

  • LBA Wealth Management held 40 shares of Elevance Health worth $7K as of Q1 2017.
  • LBA Wealth Management left its Elevance Health share count unchanged in Q1 2017.
  • Elevance Health made up ﹤0.01% of LBA Wealth Management's portfolio in Q1 2017, its #340 holding.
  • LBA Wealth Management first reported a position in Elevance Health in Q3 2014 and has held it in 9 quarters since.
  • LBA Wealth Management's Elevance Health position peaked at $36K in Q2 2015.
  • 795 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.